Armata Pharmaceuticals, Inc. (ARMP)
NYSEAMERICAN: ARMP · Real-Time Price · USD
1.580
-0.070 (-4.24%)
At close: Mar 28, 2025, 4:00 PM
1.630
+0.050 (3.16%)
After-hours: Mar 28, 2025, 7:07 PM EST
Armata Pharmaceuticals Market Cap
Armata Pharmaceuticals has a market cap or net worth of $57.17 million as of March 31, 2025. Its market cap has decreased by -54.15% in one year.
Market Cap
57.17M
Enterprise Value
174.39M
1-Year Change
-54.15%
Ranking
Category
Stock Price
$1.58
Market Cap Chart
Since December 1, 1998, Armata Pharmaceuticals's market cap has increased from $49.80M to $57.17M, an increase of 14.80%. That is a compound annual growth rate of 0.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 28, 2025 | 57.20M | -14.50% |
| Dec 31, 2024 | 66.90M | -42.87% |
| Dec 29, 2023 | 117.10M | 161.38% |
| Dec 30, 2022 | 44.80M | -69.81% |
| Dec 31, 2021 | 148.40M | 165.95% |
| Dec 31, 2020 | 55.80M | 72.76% |
| Dec 31, 2019 | 32.30M | 375.00% |
| Dec 31, 2018 | 6.80M | -29.17% |
| Dec 29, 2017 | 9.60M | 95.92% |
| Dec 30, 2016 | 4.90M | -79.06% |
| Dec 31, 2015 | 23.40M | -40.46% |
| Dec 31, 2014 | 39.30M | 281.55% |
| Dec 31, 2013 | 10.30M | 178.38% |
| Dec 31, 2012 | 3.70M | 60.87% |
| Dec 30, 2011 | 2.30M | -68.92% |
| Dec 31, 2010 | 7.40M | 27.59% |
| Dec 31, 2009 | 5.80M | 31.82% |
| Dec 31, 2008 | 4.40M | -85.57% |
| Dec 31, 2007 | 30.50M | -47.86% |
| Dec 29, 2006 | 58.50M | 39.62% |
| Dec 30, 2005 | 41.90M | -66.88% |
| Dec 31, 2004 | 126.50M | -12.76% |
| Dec 31, 2003 | 145.00M | 621.39% |
| Dec 31, 2002 | 20.10M | -83.21% |
| Dec 31, 2001 | 119.70M | -58.35% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 738.61B |
| UnitedHealth Group | 472.03B |
| Johnson & Johnson | 394.52B |
| AbbVie | 363.15B |
| Novo Nordisk | 305.46B |
| AstraZeneca | 229.16B |
| Abbott Laboratories | 226.88B |
| Merck & Co. | 225.40B |